Nightstar Therapeutics PLC (NITE)

25.50
2.28 8.21
NASDAQ : Health Technology
Prev Close 27.78
Open 27.92
Day Low/High 25.00 / 28.33
52 Wk Low/High 10.01 / 29.55
Volume 122.02K
Avg Volume 115.00K
Exchange NASDAQ
Shares Outstanding 28.10M
Market Cap 746.49M
EPS -1.60
Div & Yield N.A. (N.A)

Latest News

Nightstar Therapeutics Announces Initiation Of STAR Phase 3 Registrational Trial For NSR-REP1 In Choroideremia

Nightstar Therapeutics Announces Initiation Of STAR Phase 3 Registrational Trial For NSR-REP1 In Choroideremia

First-Ever Phase 3 Choroideremia Gene Therapy Trial

Nightstar Therapeutics Enters Oversold Territory (NITE)

Nightstar Therapeutics Enters Oversold Territory (NITE)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Nightstar Announces Pricing Of Initial Public Offering

Nightstar Announces Pricing Of Initial Public Offering

Nightstar Therapeutics plc ("Nightstar" or the "Company"), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced the pricing of its initial public offering in the...

Houlihan Lokey And Knight Form Joint Marketing Alliance

Houlihan Lokey, an international investment bank, today announced a joint marketing alliance with Knight Capital Group, Inc.

Technical Setups: News Corp., RBS

These stocks, including News Corp. and Royal Bank of Scotland, could be staging a technical move.

Growth Stocks, Market Movers, Google's China Challenge

Growth Stocks, Market Movers, Google's China Challenge

Guests include Matthew Buckley, TheStreet.com contributor and options specialist, Ken Shreve, TheStreet.com's Market Movers portfolio manager and Tim Holland, co-manager for the Aston/Tamro Capital Partners Fund.

E*Trade, TD Ameritrade Talk Has Skeptic

The chatter about a hookup between E*Trade and TD Ameritrade heated up again earlier this month, but Raymond James isn't buying it.

Sector Snap: New Ratings On Brokerages, Exchanges

Sector Snap: Goldman downgrades Jefferies, upgrades Nasdaq in update on financial sector

'Mad Money Lightning Round': Stick With ADC Telecom

'Mad Money Lightning Round': Stick With ADC Telecom

Cramer says he would be a buyer at under $6 a share.

Cramer's 'Mad Money' Recap: Next Week's Game Plan (Final)

Cramer's 'Mad Money' Recap: Next Week's Game Plan (Final)

Cramer lays out a strategy for investors to go bargain hunting during a holiday-shortened week.

Cramer's 'Mad Money' Follow-Up: Nov. 17

Cramer's 'Mad Money' Follow-Up: Nov. 17

Here's how some of Monday's 'Mad Money' stocks fared on Tuesday.

'Mad Money Lightning Round': Stay Away From Potash

'Mad Money Lightning Round': Stay Away From Potash

Cramer says he doesn't understand why the stock is up when the fundamentals are bad.

Cramer's 'Mad Money' Recap: The Bernanke Bounce (Final)

Cramer's 'Mad Money' Recap: The Bernanke Bounce (Final)

Cramer says the Fed chairman's speech today showed once again he knows what it takes to get the economy to recover.

Chairman Sells $6.5M Worth of Eastman Chemical

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

'Under the Radar' Picks for Oct. 19-23

Federated Investors, Peet's Coffee and Carbo Ceramics were featured in 'Under the Radar' this week.

Knight Capital 3Q Profit Falls, Shares Follow

Knight Capital 3Q Profit Falls, Shares Follow

Knight Capital Group says 3Q profit falls 19 pct, misses Street view; stock drops

Three Bank Stocks With More Reward, Less Risk

Three Bank Stocks With More Reward, Less Risk

Federated Investors, Knight Capital and W.P. Carey lend exposure to financial services without the travails of the loan-heavy behemoths.

Shares Of Exchanges Fall With Downgrades, Market

Shares Of Exchanges Fall With Downgrades, Market

Shares of exchanges fall as analyst predicts increased competition, issues downgrades

Lance, Teva: Top 5 Fast-Growth Stocks

Lance, Teva: Top 5 Fast-Growth Stocks

Lance, Teva Pharmaceuticals, NCI, Emergency Medical Services and Knight Capital are 'buy'-rated stocks.

Lance, Teva, NCI: Fast-Growth Stocks

Lance, Teva, NCI: Fast-Growth Stocks

Lance, Teva Pharmaceuticals, NCI, Bio-Reference Labs and Knight Capital are 'buy' rated stocks.

Lance, Teva, NCI: Fast-Growth Stocks

Lance, Teva, NCI: Fast-Growth Stocks

Lance and Teva are among fast-growth stocks that receive 'buy' recommendations from TheStreet.com.

Cramer's 'Mad Money' Follow-Up: Sept. 17

Here's how some of Wednesday's 'Mad Money' stocks fared on Thursday.

Knight Capital Trades Nearly Double From Year Ago

Knight Capital Trades Nearly Double From Year Ago

Knight Capital trade volume nearly doubles from a year ago, up 5.4 percent from July